| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc4994b001c65e1566670b1cc698a88c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62d56c0dac86d852b317072fd1d292d9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-50 |
| filingDate |
2012-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d16ab3ed53ed50659932d3f594a1d434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d16b067af1eb92219ef01ad30491f0a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aed11ddb48c62379cdbe4020d5504f1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7031cd7287c0fb062434e4255fce57c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa977478c0d580779984fc1689c3caed |
| publicationDate |
2018-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-I619496-B |
| titleOfInvention |
Pharmaceutical composition of hydrophobic camptothecin derivative |
| abstract |
The present invention provides a pharmaceutical composition comprising at least one hydrophobic camptothecin derivative or a pharmaceutically acceptable salt of the derivative and a polyethylene glycol (PEG) -bound phospholipid. A method for suppressing cancer cells in an individual in need thereof by administering the pharmaceutical composition of the present invention is also provided. |
| priorityDate |
2011-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |